| Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334) |
|---|
| 06/02/2004 | EP1423116A1 Method of treating alcoholism or alcohol abuse |
| 06/02/2004 | CN1500786A Novel buprenorphine ester derivatives and process for preparing the same and medical compounds with long-acting analgesic effect |
| 05/27/2004 | WO2004043964A2 Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
| 05/27/2004 | US20040102468 Controlling discharge of urine |
| 05/26/2004 | EP1422230A1 Novel ester derivatives of buprenorphine and their preparation processes, and long acting analgestic pharmaceutical compositions |
| 05/26/2004 | EP1421085A2 Process for the preparation of a 14-hydroxynormorphinone derivative |
| 05/19/2004 | EP1419774A1 Pharmaceutical formulations and methods comprising intranasal morphine |
| 05/19/2004 | EP1200089B1 Pyridomorphinans and use thereof |
| 05/19/2004 | CN1150196C Morphinane derivatives and medicinal use thereof |
| 05/13/2004 | WO2004039317A2 Analogs and prodrugs of buprenorphine |
| 05/13/2004 | WO2004005294A3 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
| 05/11/2004 | US6733783 Controlled release hydrocodone formulations |
| 05/06/2004 | WO2004037826A2 Preparation of codeine from morphine |
| 05/06/2004 | US20040087605 N-but-3-enyl norbuprenorphine and methods of use |
| 05/06/2004 | CA2502935A1 Preparation of codeine from morphine |
| 04/22/2004 | WO2004033458A1 Amidine compounds |
| 04/22/2004 | WO2004033457A1 Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| 04/22/2004 | US20040077863 N-demethylating an N-methyl morphinane by oxidizing an N-methyl morphinane to form the N-oxide, then treating with a reducing agent; a Delta 6,Delta 8-morphinane compound |
| 04/22/2004 | CA2501389A1 Remedies or preventives for frequent urination or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| 04/20/2004 | US6723894 Production of thebaine and oripavine |
| 04/13/2004 | CA2374877C Pharmaceutical formulations and methods comprising intranasal morphine |
| 04/13/2004 | CA2296035C Preparation of oxymorphone, oxycodone and derivatives |
| 04/08/2004 | WO2004029059A1 N-substituted hydromorphones and the use thereof |
| 04/08/2004 | US20040067973 N-substituted hydromorphones and the use thereof |
| 04/08/2004 | US20040067959 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 04/07/2004 | EP1404341A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 04/07/2004 | EP0894799B1 Indolomorphinane derivatives and remedies/preventives for cerebral disorders |
| 04/01/2004 | WO2004026819A2 OPIATE ANALOGS SELECTIVE FOR THE delta-OPIOID RECEPTOR |
| 04/01/2004 | US20040062812 Drug in mixture of matrix forming polymer and ion exchange resin |
| 04/01/2004 | CA2498046A1 Opiate analogs selective for the delta-opioid receptor |
| 03/31/2004 | EP1402899A1 Remedies for sepsis |
| 03/25/2004 | US20040058970 Alzheimer's disease |
| 03/24/2004 | EP1399161A2 Sustained-release analgesic compounds |
| 03/18/2004 | WO2004022564A2 Alternative processes for the preparation of d- (+) -morphine, and d- (+) - morphine tartrate |
| 03/18/2004 | WO2003097608A3 Opioid and opioid-like compounds and uses thereof |
| 03/11/2004 | US20040047907 Controlled release hydrocodone formulations |
| 03/03/2004 | CN1479614A Controlled release hydrocodone formulations |
| 02/26/2004 | WO2004016618A1 Oxycodone-hydrochloride polymorhs |
| 02/26/2004 | WO2003018588B1 Process for the preparation of a 14-hydroxynormorphinone derivative |
| 02/26/2004 | CA2495182A1 Oxycodone-hydrochloride polymorphs |
| 02/25/2004 | EP1390023A2 Pharmaceutical salts |
| 02/19/2004 | US20040033253 Transdermal-delivery device |
| 02/18/2004 | EP0759922B1 New antagonist compounds |
| 02/17/2004 | US6693179 Morphine-6-glucuronide synthesis |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040029905 Using codeine, hydrocodeine, meptazinol, tilidine, propoxyphene |
| 02/11/2004 | EP0820288B1 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
| 02/05/2004 | DE10229842A1 Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung Morphinan derivatives and their quaternary ammonium salts substituted in position 14, manufacturing process and use |
| 01/29/2004 | US20040019070 Nitrogen compounds used as opiate receptor agonists or antagonists, for prophylaxis of drug abuse, cardiovascular, respiratory system, gastrointestinal disorders, as analgesics, antitussives or immunosuppressants |
| 01/15/2004 | WO2004005294A2 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
| 01/15/2004 | CA2491689A1 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof |
| 01/14/2004 | EP1380306A1 Remedies for psychoneurosis |
| 01/13/2004 | US6677346 Methods comprising intranasal morphine |
| 12/18/2003 | WO2002067916A3 Pharmaceutical salts |
| 12/10/2003 | EP1368356A2 N-but-3-enyl norbuprenorphine and its use as analgesic |
| 12/10/2003 | EP1368023A1 Utilization of buprenorphine in urinary incontinence therapy |
| 12/04/2003 | WO2003074526A3 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography |
| 11/27/2003 | WO2003097608A2 Opioid and opioid-like compounds and uses thereof |
| 11/27/2003 | WO2003018588A3 Process for the preparation of a 14-hydroxynormorphinone derivative |
| 11/27/2003 | US20030219494 Compositions and methods of using them |
| 11/27/2003 | CA2486157A1 Opioid and opioid-like compounds and uses thereof |
| 11/20/2003 | WO2003095458A1 Microbial n- and o-demethylation of a thebaine derivative |
| 11/13/2003 | US20030211164 Method for preparing microparticles having a selected polymer molecular weight |
| 11/11/2003 | US6645965 Nitrate salts of antihypertensive medicines |
| 11/05/2003 | EP1359146A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 10/23/2003 | US20030199484 Method for the treatment of urinary incontinence |
| 10/22/2003 | EP1353909A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 10/16/2003 | US20030194748 Method for labeling with tritium |
| 10/14/2003 | CA2114838C A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide |
| 10/02/2003 | WO2003079945A1 Method of administering buprenorphine to treat depression |
| 10/02/2003 | US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy |
| 09/25/2003 | WO2003078437A1 Methods and compositions comprising nitric oxide donors and opioid analgesics |
| 09/25/2003 | WO2002036573B1 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 09/25/2003 | US20030181475 Method of administering buprenorphine to treat depression |
| 09/25/2003 | CA2479098A1 Methods and compositions comprising nitric oxide donors and opioid analgesics |
| 09/12/2003 | WO2003074526A2 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography |
| 09/12/2003 | CA2477739A1 Method and system for separation and purification of at least one narcotic alkaloid using reverse phase preparative chromatography |
| 08/28/2003 | WO2003070191A2 Tamper-resistant transdermal opioid delivery devices |
| 08/27/2003 | EP1337254A2 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence |
| 08/27/2003 | EP1337244A1 Controlled release hydrocodone formulations |
| 08/21/2003 | WO2002036573A3 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 08/21/2003 | US20030157565 Haptens, immunogens and antibodies to oxycodone and its metabolites |
| 08/14/2003 | US20030153590 Method of treating alcoholism or alcohol abuse |
| 08/07/2003 | WO2003063779A2 Selective analgesic agents |
| 08/07/2003 | CA2474306A1 Selective analgesic agents |
| 07/31/2003 | WO2003061632A1 Method of treatment of a patient requiring analgesia |
| 07/31/2003 | US20030143279 Method for preparing microparticles having a selected polymer molecular weight |
| 07/31/2003 | CA2473884A1 Method of treatment of a patient requiring analgesia |
| 07/16/2003 | EP1327444A1 Antipruritic agent |
| 07/16/2003 | EP1326869A1 Pyrrole-condensed morphinoid derivatives |
| 07/16/2003 | EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists |
| 07/08/2003 | US6589960 Preparation of a ketone from a narcotic alkaloid having an allyl alcohol moiety is disclosed. The method includes mixing the narcotic alkaloid with an acid in the presence of a catalyst wherein the method is carried out in the absence of |
| 07/02/2003 | EP1323718A2 Haptens, immunogens and antibodies to oxycodone and its metabolites |
| 06/26/2003 | WO2003051888A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 06/24/2003 | US6583151 Remedies for drug addiction |
| 06/17/2003 | US6579985 Methylating under reflux in aromatic hydrocarbon solvent without etherification |
| 05/28/2003 | CN1109672C Process for prodn. of (Z)-1-[1-(4-methoxybenzylidene)-1,2,3,4,5,6,7,8-octahydro-isoquinolin-2-yl] alkanones |
| 05/21/2003 | EP1312361A1 Antipruritic agent |
| 05/20/2003 | US6566510 Morphine-6-glucuronide synthesis |
| 05/14/2003 | EP1310255A1 Antipruritic agent |